Using clinical registries to inform trial design
Collective expertise develops smart approaches to clinical trials
Approaches to clinical trials are changing with the trend towards personalised medicine, as the discovery of new biomarkers and genetic mutations for smaller populations create a difficult environment for designing clinical trials.
Increasingly, cancer treatments target small populations, are given in combination, and at times, pose a significant cost to the health system. Through the VCCC’s alliance collective expertise, there is an opportunity to develop smart, adaptive clinical trials to translate discoveries and enable improved patient health outcomes.